{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:12:09Z","timestamp":1781910729170,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bruyere Research Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is abundant evidence for sex differences in the diagnosis, implantation, and outcomes for cardiac resynchronization therapy (CRT) devices. Controversial data suggesting women are less likely to receive the device regardless of the greater benefit. The aim of this review is to assess sex differences in the implantation rate, clinical effectiveness, and safety of patients receiving CRT devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We will conduct a systematic literature search of MEDLINE, Embase, and Web of Science to identify cohort studies that meet our eligibility criteria. Title and full text screening will be conducted in duplicate independently. Eligible studies report clinical effectiveness or safety of patients receiving CRT device while providing sex-disaggregated data. Implantation rate will be extracted from the baseline characteristics tables of the studies. The effectiveness outcomes include the following: all-cause death, hospitalization, peak oxygen consumption (pVO\n                      <jats:sub>2<\/jats:sub>\n                      ), quality of life (QoL), 6-min walk test, NYHA class reduction, LVEF, and heart failure hospitalization. The complication outcomes include the following: contrast-induced nephropathy, pneumothorax, pocket-related hematoma, pericardial tamponade, phrenic nerve stimulation, device infection, death, pulmonary edema, electrical storm, cardiogenic shock, and hypotension requiring resuscitation. Description of included studies will be reported in detail and outcomes will be meta-analyzed and presented using forest plots when feasible. Risk of bias will be assessed using the Newcastle-Ottawa Scale (NOS) by two review authors independently. GRADE approach will be used to assess the certainty of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The aim of this review is to determine the presence of differences in CRT implantation between women and men as well as differences in clinical effectiveness and safety of CRT after device implantation. Results from this systematic review will provide important insights into sex differences in CRT devices that could contribute to the development of sex-specific recommendations and inform policy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42020204804<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-021-01746-x","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T11:03:38Z","timestamp":1627038218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sex differences in CRT device implantation rates, efficacy, and complications following implantation: protocol for a systematic review and meta-analysis of cohort studies"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-887X","authenticated-orcid":false,"given":"Omar","family":"Dewidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Podinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"issue":"7","key":"1746_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/embor.2012.87","volume":"13","author":"V Regitz-Zagrosek","year":"2012","unstructured":"Regitz-Zagrosek V. Sex and gender differences in health. Science & Society Series on Sex and Science. EMBO Rep. 2012;13(7):596\u2013603. https:\/\/doi.org\/10.1038\/embor.2012.87.","journal-title":"EMBO Rep"},{"key":"1746_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.022","volume-title":"Sex and gender aspects in clinical medicine","author":"S Oertelt-Prigione","year":"2012","unstructured":"Oertelt-Prigione S, Regitz-Zagrosek V. Sex and gender aspects in clinical medicine. London, UK: Springer; 2012. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.022."},{"issue":"2","key":"1746_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1573403X11309020006","volume":"9","author":"JE Blair","year":"2013","unstructured":"Blair JE, Huffman M, Shah SJ. Heart failure in North America. Curr Cardiol Rev. 2013;9(2):128\u201346. https:\/\/doi.org\/10.2174\/1573403X11309020006.","journal-title":"Curr Cardiol Rev"},{"issue":"12","key":"1746_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12471-010-0841-y","volume":"18","author":"AH Maas","year":"2010","unstructured":"Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Hear J. 2010;18(12):598\u2013602. https:\/\/doi.org\/10.1007\/s12471-010-0841-y.","journal-title":"Neth Hear J"},{"issue":"7","key":"1746_CR5","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1253\/circj.CJ-10-0196","volume":"74","author":"V Regitz-Zagrosek","year":"2010","unstructured":"Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J. 2010;74(7):1265\u201373. https:\/\/doi.org\/10.1253\/circj.CJ-10-0196.","journal-title":"Circ J"},{"issue":"24","key":"1746_CR6","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek V. Sex and gender differences in symptoms of myocardial ischaemia. Eur Heart J. 2011;32(24):3064\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehr272.","journal-title":"Eur Heart J"},{"issue":"12","key":"1746_CR7","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.jacc.2005.09.019","volume":"46","author":"JJ Bax","year":"2005","unstructured":"Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, et al. Cardiac resynchronization therapy: part 1--issues before device implantation. J Am Coll Cardiol. 2005;46(12):2153\u201367.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1746_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cjca.2012.10.006","volume":"29","author":"DV Exner","year":"2013","unstructured":"Exner DV, Birnie DH, Moe G, Thibault B, Philippon F, Healey JS, et al. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection. Can J Cardiol. 2013;29(2):182\u201395. https:\/\/doi.org\/10.1016\/j.cjca.2012.10.006.","journal-title":"Can J Cardiol"},{"issue":"2","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138(2):198\u2013205. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034271.","journal-title":"Circulation."},{"issue":"8","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.118.037369","volume":"139","author":"EM Hsich","year":"2019","unstructured":"Hsich EM. Sex differences in advanced heart failure therapies. Circulation. 2019;139(8):1080\u201393. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037369.","journal-title":"Circulation."},{"issue":"19","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/eurheartj\/ehw598","volume":"38","author":"NA Chatterjee","year":"2017","unstructured":"Chatterjee NA, Borgquist R, Chang Y, Lewey J, Jackson VA, Singh JP, et al. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator. Eur Heart J. 2017;38(19):1485\u201394. https:\/\/doi.org\/10.1093\/eurheartj\/ehw598.","journal-title":"Eur Heart J"},{"key":"1746_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ahj.2017.04.001","volume":"189","author":"TC Randolph","year":"2017","unstructured":"Randolph TC, Hellkamp AS, Zeitler EP, Fonarow GC, Hernandez AF, Thomas KL, et al. Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. Am Heart J. 2017;189:48\u201358. https:\/\/doi.org\/10.1016\/j.ahj.2017.04.001.","journal-title":"Am Heart J"},{"issue":"10","key":"1746_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ejhf.781","volume":"19","author":"LH Lund","year":"2017","unstructured":"Lund LH, Braunschweig F, Benson L, St\u00e5hlberg M, Dahlstr\u00f6m U, Linde C. Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry. Eur J Heart Fail. 2017;19(10):1270\u20139. https:\/\/doi.org\/10.1002\/ejhf.781.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"1746_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003108","volume":"9","author":"AR Sridhar","year":"2016","unstructured":"Sridhar AR, Yarlagadda V, Parasa S, Reddy YM, Patel D, Lakkireddy D, et al. Cardiac resynchronization therapy: US trends and disparities in utilization and outcomes. Circ Arrhythm Electrophysiol. 2016;9(3):e003108. https:\/\/doi.org\/10.1161\/CIRCEP.115.003108.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"1746_CR15","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.amjcard.2014.03.049","volume":"113","author":"PM Schneider","year":"2014","unstructured":"Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, et al. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014;113(12):2052\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.049.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1746_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1540-8159.2008.01016.x","volume":"31","author":"J Alaeddini","year":"2008","unstructured":"Alaeddini J, Wood MA, Amin MS, Ellenbogen KA. Gender disparity in the use of cardiac resynchronization therapy in the United States. Pacing Clin Electrophysiol. 2008;31(4):468\u201372. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.01016.x.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"1746_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/jce.12438","volume":"25","author":"D Jamerson","year":"2014","unstructured":"Jamerson D, McNitt S, Polonsky S, Zareba W, Moss A, Tompkins C. Early procedure-related adverse events by gender in MADIT-CRT. J Cardiovasc Electrophysiol. 2014;25(9):985\u20139. https:\/\/doi.org\/10.1111\/jce.12438.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"1746_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1540-8159.2010.02703.x","volume":"33","author":"H Ghanbari","year":"2010","unstructured":"Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, et al. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol. 2010;33(4):400\u20136. https:\/\/doi.org\/10.1111\/j.1540-8159.2010.02703.x.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"14","key":"1746_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329\u201338. https:\/\/doi.org\/10.1056\/NEJMoa0906431.","journal-title":"N Engl J Med"},{"issue":"25","key":"1746_CR20","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"AS Tang","year":"2010","unstructured":"Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1009540.","journal-title":"N Engl J Med"},{"issue":"23","key":"1746_CR21","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","volume":"52","author":"C Linde","year":"2008","unstructured":"Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1746_CR22","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jamainternmed.2014.2717","volume":"174","author":"R Zusterzeel","year":"2014","unstructured":"Zusterzeel R, Selzman KA, Sanders WE, Ca\u00f1os DA, O'Callaghan KM, Carpenter JL, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. JAMA Intern Med. 2014;174(8):1340\u20138. https:\/\/doi.org\/10.1001\/jamainternmed.2014.2717.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1746_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/jwh.2014.4980","volume":"24","author":"ND Herz","year":"2015","unstructured":"Herz ND, Engeda J, Zusterzeel R, Sanders WE, O'Callaghan KM, Strauss DG, et al. Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events. J Women's Health (Larchmt). 2015;24(4):261\u201371.","journal-title":"J Women's Health (Larchmt)"},{"key":"1746_CR24","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Bmj. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"Bmj."},{"key":"1746_CR25","doi-asserted-by":"crossref","unstructured":"McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV, Thomas J. Defining the criteria for including studies and how they will be grouped for the synthesis. Cochrane Handbook for Systematic Reviews of Interventions. 2019:33\u201365.","DOI":"10.1002\/9781119536604.ch3"},{"issue":"1","key":"1746_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/jpm.2008.9690","volume":"12","author":"MD Carlson","year":"2009","unstructured":"Carlson MD, Morrison RS. Study design, precision, and validity in observational studies. J Palliat Med. 2009;12(1):77\u201382. https:\/\/doi.org\/10.1089\/jpm.2008.9690.","journal-title":"J Palliat Med"},{"key":"1746_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1553","volume":"344","author":"X Sun","year":"2012","unstructured":"Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553. https:\/\/doi.org\/10.1136\/bmj.e1553.","journal-title":"BMJ."},{"issue":"9454","key":"1746_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","volume":"365","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365(9454):176\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(05)17709-5.","journal-title":"Lancet."},{"key":"1746_CR29","doi-asserted-by":"publisher","DOI":"10.3354\/dao03357","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition ed","author":"H Julian","year":"2019","unstructured":"Julian H, James T, Jacqueline C, Miranda C, Tianjing L, Matthew P, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition ed. Chichester (UK): John Wiley & Sons; 2019. https:\/\/doi.org\/10.3354\/dao03357."},{"issue":"1","key":"1746_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4(1):1.","journal-title":"Systematic Reviews"},{"issue":"1","key":"1746_CR31","first-page":"21","volume":"19","author":"AM Gillis","year":"2003","unstructured":"Gillis AM, Philippon F, Cassidy MR, Singh N, Dorian P, Love BA, et al. Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol. 2003;19(1):21\u201337.","journal-title":"Can J Cardiol"},{"issue":"29","key":"1746_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281\u2013329.","journal-title":"Eur Heart J"},{"issue":"2","key":"1746_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCEP.110.959791","volume":"4","author":"D Krahn Andrew","year":"2011","unstructured":"Krahn Andrew D, Lee Douglas S, Birnie D, Healey Jeffrey S, Crystal E, Dorian P, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement. Circ Arrhythm Electrophysiol. 2011;4(2):136\u201342.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"16","key":"1746_CR34","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/jama.295.16.1907","volume":"295","author":"PA Gould","year":"2006","unstructured":"Gould PA, Krahn AD. Canadian Heart Rhythm Society Working Group on Device Advisories ft. complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295(16):1907\u201311. https:\/\/doi.org\/10.1001\/jama.295.16.1907.","journal-title":"JAMA."},{"issue":"6","key":"1746_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/europace\/eun122","volume":"10","author":"BL Wilkoff","year":"2008","unstructured":"Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, et al. HRS\/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008;10(6):707\u201325.","journal-title":"Europace"},{"key":"1746_CR36","unstructured":"Study design search filters: BMJ Best Practice; [Available from: https:\/\/bestpractice.bmj.com\/info\/toolkit\/learn-ebm\/study-design-search-filters\/."},{"key":"1746_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2288-11-12","volume":"11","author":"RA Damarell","year":"2011","unstructured":"Damarell RA, Tieman J, Sladek RM, Davidson PM. Development of a heart failure filter for Medline: an objective approach using evidence-based clinical practice guidelines as an alternative to hand searching. BMC Med Res Methodol. 2011;11:12.","journal-title":"BMC Med Res Methodol"},{"key":"1746_CR38","unstructured":"Innovation VH. Covidence systematic review software. Melbourne. Australia."},{"key":"1746_CR39","doi-asserted-by":"crossref","unstructured":"Li T, Higgins JPT, Deeks JJ. Collecting data. Cochrane Handbook for Systematic Reviews of Interventions. 2019:109\u201341.","DOI":"10.1002\/9781119536604.ch5"},{"key":"1746_CR40","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D.A., Peterson, J., Welch, V., Losos, M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2013 [Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"1746_CR41","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. Cochrane Handbook for Systematic Reviews of Interventions. 2019:143\u201376.","DOI":"10.1002\/9781119536604.ch6"},{"key":"1746_CR42","doi-asserted-by":"publisher","DOI":"10.17226\/25375","volume-title":"Review Manager Web (RevMan Web)","author":"Collaboration TC","year":"2019","unstructured":"Collaboration TC. Review Manager Web (RevMan Web); 2019. https:\/\/doi.org\/10.17226\/25375."},{"key":"1746_CR43","first-page":"241","volume-title":"Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions","author":"JJ Deeks","year":"2019","unstructured":"Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods G. Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions; 2019. p. 241\u201384."},{"key":"1746_CR44","doi-asserted-by":"crossref","unstructured":"Page MJ, Higgins JPT, Sterne JAC. Assessing risk of bias due to missing results in a synthesis. Cochrane Handbook for Systematic Reviews of Interventions. 2019:349\u201374.","DOI":"10.1002\/9781119536604.ch13"},{"key":"1746_CR45","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence. Cochrane Handbook for Systematic Reviews of Interventions. 2019:375\u2013402.","DOI":"10.1002\/9781119536604.ch14"},{"issue":"7","key":"1746_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jama.286.7.821","volume":"286","author":"JP Ioannidis","year":"2001","unstructured":"Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001;286(7):821\u201330. https:\/\/doi.org\/10.1001\/jama.286.7.821.","journal-title":"JAMA."},{"issue":"5","key":"1746_CR47","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jacc.2005.05.064","volume":"46","author":"DN Wijeysundera","year":"2005","unstructured":"Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol. 2005;46(5):872\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"1746_CR48","doi-asserted-by":"publisher","unstructured":"Hartz A, Bentler S, Charlton M, Lanska D, Butani Y, Soomro GM, et al. Assessing observational studies of medical treatments. Emerging themes in epidemiology [Internet]. 2005 2005\/09\/\/; 2:[8 p.]. Available from: http:\/\/europepmc.org\/abstract\/MED\/16137327Available from: https:\/\/doi.org\/10.1186\/1742-7622-2-8Available from: https:\/\/europepmc.org\/articles\/PMC1215501Available from: https:\/\/europepmc.org\/articles\/PMC1215501?pdf=render.","DOI":"10.1186\/1742-7622-2-8Available"},{"issue":"25","key":"1746_CR49","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","volume":"342","author":"K Benson","year":"2000","unstructured":"Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342(25):1878\u201386. https:\/\/doi.org\/10.1056\/NEJM200006223422506.","journal-title":"N Engl J Med"},{"issue":"25","key":"1746_CR50","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887\u201392. https:\/\/doi.org\/10.1056\/NEJM200006223422507.","journal-title":"N Engl J Med"},{"key":"1746_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1745-6215-10-9","volume":"10","author":"JA Cook","year":"2009","unstructured":"Cook JA. The challenges faced in the design, conduct and analysis of surgical randomised controlled trials. Trials. 2009;10:9.","journal-title":"Trials."},{"issue":"7351","key":"1746_CR52","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1136\/bmj.324.7351.1448","volume":"324","author":"P McCulloch","year":"2002","unstructured":"McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ. 2002;324(7351):1448\u201351. https:\/\/doi.org\/10.1136\/bmj.324.7351.1448.","journal-title":"BMJ."},{"issue":"8972","key":"1746_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(95)92774-3","volume":"346","author":"J Ellis","year":"1995","unstructured":"Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet. 1995;346(8972):407\u201310.","journal-title":"Lancet."},{"issue":"9","key":"1746_CR54","first-page":"1220","volume":"84","author":"N Howes","year":"1997","unstructured":"Howes N, Chagla L, Thorpe M, McCulloch P. Surgical practice is evidence based. Br J Surg. 1997;84(9):1220\u20133.","journal-title":"Br J Surg"},{"issue":"13","key":"1746_CR55","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2020.01.048","volume":"75","author":"M Gaudino","year":"2020","unstructured":"Gaudino M, Kappetein AP, Di Franco A, Bagiella E, Bhatt DL, Boening A, et al. Randomized trials in cardiac surgery. J Am Coll Cardiol. 2020;75(13):1593. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.048.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1746_CR56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2190\/986L-LHQ6-2VTE-YRRN","volume":"22","author":"M Whitehead","year":"1992","unstructured":"Whitehead M. The concepts and principles of equity and health. Int J Health Serv. 1992;22(3):429\u201345. https:\/\/doi.org\/10.2190\/986L-LHQ6-2VTE-YRRN.","journal-title":"Int J Health Serv"},{"issue":"3","key":"1746_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.pec.2009.07.010","volume":"76","author":"H Sandhu","year":"2009","unstructured":"Sandhu H, Adams A, Singleton L, Clark-Carter D, Kidd J. The impact of gender dyads on doctor-patient communication: a systematic review. Patient Educ Couns. 2009;76(3):348\u201355. https:\/\/doi.org\/10.1016\/j.pec.2009.07.010.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"1746_CR58","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/14017431.2017.1385837","volume":"51","author":"C Carnl\u00f6f","year":"2017","unstructured":"Carnl\u00f6f C, Iwarzon M, Jensen-Urstad M, Gadler F, Insulander P. Women with PSVT are often misdiagnosed, referred later than men, and have more symptoms after ablation. Scand Cardiovasc J. 2017;51(6):299\u2013307. https:\/\/doi.org\/10.1080\/14017431.2017.1385837.","journal-title":"Scand Cardiovasc J"},{"issue":"10","key":"1746_CR59","doi-asserted-by":"publisher","first-page":"1565-ao","DOI":"10.1093\/europace\/euy067","volume":"20","author":"C Linde","year":"2018","unstructured":"Linde C, Bongiorni MG, Birgersdotter-Green U, Curtis AB, Deisenhofer I, Furokawa T, et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace. 2018;20(10):1565-ao.","journal-title":"Europace"},{"issue":"8","key":"1746_CR60","first-page":"919","volume":"132","author":"GH Guyatt","year":"1985","unstructured":"Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132(8):919\u201323.","journal-title":"Can Med Assoc J"},{"key":"1746_CR61","unstructured":"Dolgin M, Criteria Committee of the New York Heart A, New York Heart Association. Criteria C, Fox AC, Levin RI. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels: Little, Brown; 1994."},{"issue":"4","key":"1746_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1054\/jcaf.2000.20841","volume":"6","author":"WT Abraham","year":"2000","unstructured":"Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6(4):369\u201380. https:\/\/doi.org\/10.1054\/jcaf.2000.20841.","journal-title":"J Card Fail"},{"issue":"20","key":"1746_CR63","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","volume":"289","author":"JB Young","year":"2003","unstructured":"Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685\u201394. https:\/\/doi.org\/10.1001\/jama.289.20.2685.","journal-title":"JAMA."},{"issue":"3","key":"1746_CR64","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1054\/jcaf.2000.9501","volume":"6","author":"MR Bristow","year":"2000","unstructured":"Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail. 2000;6(3):276\u201385. https:\/\/doi.org\/10.1054\/jcaf.2000.9501.","journal-title":"J Card Fail"},{"issue":"12","key":"1746_CR65","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/0002-9149(93)90582-W","volume":"71","author":"TS Rector","year":"1993","unstructured":"Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71(12):1106\u20137. https:\/\/doi.org\/10.1016\/0002-9149(93)90582-W.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1746_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HCO.0b013e32831bc63b","volume":"24","author":"AS Tang","year":"2009","unstructured":"Tang AS, Wells GA, Arnold M, Connolly S, Hohnloser S, Nichol G, et al. Resynchronization\/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol. 2009;24(1):1\u20138. https:\/\/doi.org\/10.1097\/HCO.0b013e32831bc63b.","journal-title":"Curr Opin Cardiol"},{"issue":"16","key":"1746_CR67","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","volume":"122","author":"JE Poole","year":"2010","unstructured":"Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.976076.","journal-title":"Circulation."},{"issue":"24","key":"1746_CR68","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","volume":"72","author":"AD Krahn","year":"2018","unstructured":"Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, et al. Prevention of Arrhythmia Device Infection Trial: the PADIT Trial. J Am Coll Cardiol. 2018;72(24):3098\u2013109.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1746_CR69","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ejheart.2004.10.023","volume":"7","author":"PJ Cowburn","year":"2005","unstructured":"Cowburn PJ, Patel H, Pipes RR, Parker JD. Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. Eur J Heart Fail. 2005;7(5):899\u2013903. https:\/\/doi.org\/10.1016\/j.ejheart.2004.10.023.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1746_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cjca.2012.02.019","volume":"28","author":"G Sharma","year":"2012","unstructured":"Sharma G, Senguttuvan NB, Thachil A, Leong D, Naik N, Yadav R, et al. A comparison of lead placement through the subclavian vein technique with fluoroscopy-guided axillary vein technique for permanent pacemaker insertion. Can J Cardiol. 2012;28(5):542\u20136. https:\/\/doi.org\/10.1016\/j.cjca.2012.02.019.","journal-title":"Can J Cardiol"},{"issue":"22","key":"1746_CR71","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1302946.","journal-title":"N Engl J Med"},{"issue":"7","key":"1746_CR72","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMra022643","volume":"349","author":"DH Spodick","year":"2003","unstructured":"Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349(7):684\u201390. https:\/\/doi.org\/10.1056\/NEJMra022643.","journal-title":"N Engl J Med"},{"issue":"4","key":"1746_CR73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/CIRCEP.108.836254","volume":"2","author":"M Biffi","year":"2009","unstructured":"Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I, et al. Phrenic stimulation. Circ Arrhythm Electrophysiol. 2009;2(4):402\u201310.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"24","key":"1746_CR74","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","volume":"288","author":"BL Wilkoff","year":"2002","unstructured":"Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115\u201323. https:\/\/doi.org\/10.1001\/jama.288.24.3115.","journal-title":"JAMA."},{"issue":"18","key":"1746_CR75","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","volume":"35","author":"RE Kirkfeldt","year":"2013","unstructured":"Kirkfeldt RE, Johansen JB, Nohr EA, J\u00f8rgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2013;35(18):1186\u201394.","journal-title":"Eur Heart J"},{"issue":"3","key":"1746_CR76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eut304","volume":"16","author":"F Guerra","year":"2013","unstructured":"Guerra F, Shkoza M, Scappini L, Flori M, Capucci A. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. EP Europace. 2013;16(3):347\u201353.","journal-title":"EP Europace"},{"issue":"9","key":"1746_CR77","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1253\/circj.CJ-10-0092","volume":"74","author":"M Takigawa","year":"2010","unstructured":"Takigawa M, Noda T, Kurita T, Aihara N, Yamada Y, Okamura H, et al. Predictors of electrical storm in patients with idiopathic dilated cardiomyopathy \u2013 how to stratify the risk of electrical storm. Circ J. 2010;74(9):1822\u20139. https:\/\/doi.org\/10.1253\/circj.CJ-10-0092.","journal-title":"Circ J"},{"issue":"14","key":"1746_CR78","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","volume":"51","author":"JP Daubert","year":"2008","unstructured":"Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1746_CR79","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1542-474X.2007.00187.x","volume":"12","author":"CW Israel","year":"2007","unstructured":"Israel CW, Serge BS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007;12(4):375\u201382. https:\/\/doi.org\/10.1111\/j.1542-474X.2007.00187.x.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"27","key":"1746_CR80","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-021-01746-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T11:03:53Z","timestamp":1627038233000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01746-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01746-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-93103\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}